Structure of Uridine 5 diphosphoglucose disodium salt CAS 28053 08 9 - Uridine 5'-diphosphoglucose disodium salt CAS 28053-08-9 custom Nucleotide - Uridine 5'-diphosphoglucose disodium salt CAS 28053-08-9 Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions and Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

28053-08-9

Name

Uri­dine 5′-diphosphoglucose dis­odi­um salt

Syn­onyms

(3,4-Dihydroxytetrahydro-2-furanyl)methyl 3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl dihy­dro­gen diphos­phate [ACD/IUPAC Name] (3,4-Dihydroxytetrahydro-2-furanyl)methyl-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yldihydrogendiphosphat [Ger­man] [ACD/IUPAC Name] 248-801-6 [EINECS] 28053-08-9 [RN] Dihy­drogén­odiphos­phate de (3,4-dihydroxytétrahydro-2-furanyl)méthyle et de 3,4,5-trihydroxy-6-(hydroxyméthyl)tétrahydro-2H-pyran-2-yle [French] [ACD/IUPAC Name]

Mol­e­c­u­lar Structure

Structure of Uridine 5 diphosphoglucose disodium salt CAS 28053 08 9 - Uridine 5'-diphosphoglucose disodium salt CAS 28053-08-9

Struc­ture of Uri­dine 5′-diphosphoglucose dis­odi­um salt CAS 28053-08-9

SMILES

C1C(C(C(O1)COP(=O)(O)OP(=O)(O)OC2C(C(C(C(O2)CO)O)O)O)O)O

Std­InChI

InChI=1S/C11H22O15P2/c12-1-5-8(15)9(16)10(17)11(24-5)25-28(20,21)26-27(18,19)23-3-6-7(14)4(13)2-22-6/h4-17H,1-3H2,(H,18,19)(H,20,21)

Std­InChIKey

ZZA­H­NEVHQY­WAEU-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C15H22N2Na2O17P2

Mol­e­c­u­lar Weight

610.26

EINECS

248-801-6

MDL Number

MFCD20441966

Prop­er­ties

Appear­ance

White or almost white pow­der or crys­talline pow­der

Safe­ty Data

WGK Germany

3 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Uri­dine 5′-diphosphoglucose dis­odi­um salt CAS 28053-08-9

Stan­dard

Enter­prise stan­dard

Iden­ti­fi­ca­tion Methods

HPLC/IR

Puri­ty

95%min

Loss on Drying

20%max

Con­tent

85%min

Stor­age

Pre­serve in tight,light-resistant containers,in a freez­ing place.

Appli­ca­tion

As a active sub­stance of hepato­pro­tec­tive, UDP-G can enhance liv­er detox­i­fi­ca­tion func­tion. It plays an irre​place​.able role in the treat­ment of liv­er dam­age caused by drugs and can be clin­i­cal­ly used for the treat­ment of tox­ic and infec­tious hepati­tis. And it can increase endurance for can­cer patients under­go­ing chemother­a­py by using 5-FU ，so as to enhance the ther­a­peu­tic effect. Also used as phar­ma­ceu­ti­cal inter­me­di­ates, and also can be used for the syn­the­sis of oligosac­cha­ride.

Gen­er­al View of Documents

Uridine 5 diphosphoglucose disodium salt CAS 28053 08 9 HPLC - Uridine 5'-diphosphoglucose disodium salt CAS 28053-08-9

Uri­dine 5-diphos­pho­glu­­cose dis­odi­um salt CAS 28053-08-9-HPLC

Links

This prod­uct is devel­oped by our RandD com­pa­ny Ulcho Bio­chem­i­cal Ltd (http://​www​.ulcho​.com/), and here is the cor­re­spond­ing linkhttp://​www​.ulcho​.com/​u​r​i​d​i​n​e​-​5​-​d​i​p​h​o​s​p​h​o​g​l​u​c​o​s​e​-​d​i​s​o​d​i​u​m​-​s​a​l​t​-​c​a​s​-​2​8​0​5​3​-​0​8​-9/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone). 

























    Please prove you are human by select­ing the Star.




    andD pur­pose. It may be tox­ic or haz­ardous, and should be han­dled only by qual­i­fied indi­vid­u­als trained in lab­o­ra­to­ry pro­ce­dures. The buy­er will be respon­si­ble to warn and inform any per­son that may be in con­tact with the prod­uct of the poten­tial risks and haz­ards, as well as to ensure that pur­chase, use and dis­pos­al of the prod­uct com­ply with local laws and regulations.